BellRing Brands price target raised to $54 from $48 at Barclays

Barclays analyst Andrew Lazar raised the firm’s price target on BellRing Brands to $54 from $48 and keeps an Overweight rating on the shares. The firm says that while some of the post-earnings share price rally is likely due to BellRing’s favorable commentary on its products and weight loss drugs, it would much prefer to focus on the company’s “strong core fundamental trends.” The trends could drive another year of above-algorithm performance in fiscal 2024, the analyst tells investors in a research note.